Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-25-007995
Filing Date
2025-06-27
Accepted
2025-06-27 16:16:22
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp230755_4-tennant.html 4  
1 FORM 4 dp230755_4-tennant.xml 4 4080
  Complete submission text file 0000950103-25-007995.txt   5602
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Issuer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRECIGEN, INC. 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Tennant Phil (Reporting) CIK: 0002030874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36042 | Film No.: 251086537